Defining metabolic adaptations within the PDAC "arid" tumor microenvironment
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment
批准号:
10623158
负责人:
CHI V. DANG
金额:
$54.47万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-05-01 至 2026-04-30
关键词:
AffectAmino AcidsAnimal ModelAreaBackBehaviorBiomassBlood VesselsBranched-Chain Amino AcidsCRISPR screenCancer EtiologyCell Culture TechniquesCell ProliferationCell SeparationCell SurvivalCell divisionCellsCellular Metabolic ProcessCessation of lifeCitric Acid CycleClinicalDNA DamageDependenceDiffusionEnvironmentGenerationsGenesGlucoseGoalsGrowthHeterogeneityHumanHypoxiaImmuneIn VitroIndividualInter-tumoral heterogeneityLabelLipidsMalignant NeoplasmsMetabolicMethodsModelingMolecularMyeloid-derived suppressor cellsNutrientOxidative PhosphorylationOxygenPancreatic Ductal AdenocarcinomaPathway interactionsPerfusionPharmaceutical PreparationsPhenotypeProductionProliferatingProtocols documentationResourcesSerumSourceSystemTestingTherapeuticTranslationsWarburg Effectaerobic glycolysiscancer cellcancer typecell growthchemotherapycopingdeprivationexperimental studygenome wide screenin vivoinhibitorinsightmacromoleculemetabolic abnormality assessmentmetabolic profilemetabolomicsneoplastic cellnutrient deprivationpancreatic cancer cellspancreatic ductal adenocarcinoma cellpancreatic ductal adenocarcinoma modelpancreatic neoplasmpancreatic stellate cellrefractory cancerresponsestandard of caretargeted treatmenttherapy resistanttumortumor microenvironmentwhole genome
中文摘要
项目总结
我们建议的目标是确定与营养不良条件相关的治疗脆弱性
肿瘤。胰腺导管腺癌(PDAC)仍然是一个主要的临床挑战,其特点是
间质致密,血管稀少。由此导致的缺氧和营养的匮乏迫使癌症
细胞为生长寻找替代的营养来源。矛盾的是,这些营养物质中的细胞-
由于药物扩散不良,被剥夺的微环境是对治疗最具抵抗力的人群之一
并减少细胞增殖(使DNA损伤剂的效果降低)。因此,为了针对这些细胞,
迫切需要更好地了解它们应对营养匮乏的适应机制。
需要的。
在初步研究中,我们制定了限制氧气、葡萄糖、氨基酸和血清的培养方案。
--模拟胰腺肿瘤的“干旱状况”。在这种情况下,肿瘤细胞会减慢速度
增殖和代谢活动。利用这个系统,我们进行了全基因组CRISPR筛查
确定干旱条件下所需的基因,但在营养充足(“肥沃”)条件下却是可有可无的。这
揭示了对TCA循环和氧化磷酸化生存的强烈依赖,但也表明
参与许多生物合成活动(例如,翻译和细胞分裂)的基因在干旱条件下是有害的
条件。根据这些结果,我们假设细胞在严重的营养和缺氧条件下存活下来。
通过最大限度地利用有限的燃料供应产生能源,同时将此类资源的使用降至最低
大分子生产。我们进一步假设,营养和缺氧的缺乏改变了动态
癌细胞与构成肿瘤微环境(TME)的其他细胞之间的串扰。重要的是
不同的肿瘤可能以不同的方式对这些代谢变化作出反应,从而导致肿瘤间的相互作用。
异质性。我们的提案将探索这些想法,以开发针对抗药性治疗的策略
癌细胞居住在这些营养匮乏的壁龛里。
目的1.研究干旱条件下代谢适应的异质性。
目的2.确定干旱条件如何影响TME中的蜂窝串扰。
目的3.测定代谢抑制剂在干旱条件下的体外和体内抗细胞活性。
英文摘要
PROJECT SUMMARY
The goal of our proposal is to identify therapeutic vulnerabilities associated with nutrient-poor conditions in
tumors. Pancreatic ductal adenocarcinoma (PDAC) remains a major clinical challenge and is characterized by
a dense stroma and paucity of blood vessels. The resulting hypoxia and scarcity of nutrients forces cancer
cells to seek alternative sources of nutrients for growth. Paradoxically, cells residing in these nutrient-
deprived microenvironments are among the most resistant to therapy as a result of poor drug diffusion
and reduced cell proliferation (rendering DNA-damaging agents less effective). To target these cells, therefore,
a better understanding of the adaptive mechanisms by which they cope with nutrient deprivation is urgently
needed.
In preliminary studies, we developed a culture protocol – limiting for oxygen, glucose, amino acids, and serum
– to model the “arid conditions” of pancreatic tumors. Under such conditions, tumor cells slow down
proliferation and metabolic activity. Using this system, we performed a whole genome CRISPR screen to
identify genes required under arid conditions but dispensable under nutrient-replete (“fertile”) conditions. This
revealed a strong dependency on the TCA cycle and oxidative phosphorylation for survival, but also suggested
that genes involved in many biosynthetic activities (e.g. translation and cell division) are detrimental under arid
conditions. Based on these results, we hypothesize that cells survive severe nutrient and oxygen deprivation
by maximizing energy generation from limited fuel supplies while minimizing the use of such resources for
macromolecule production. We further hypothesize that nutrient and oxygen deprivation alters the dynamic
crosstalk between cancer cells and other cells comprising the tumor microenvironment (TME). Importantly,
individual tumors may respond to these metabolic changes in different ways, contributing to inter-tumoral
heterogeneity. Our proposal will explore these ideas to develop strategies that target therapy-resistant
cancer cells residing in these nutrient-deprived niches.
Aim 1. Characterize the heterogeneity in metabolic adaptations to arid conditions.
Aim 2. Determine how arid conditions influence cellular crosstalk in the TME.
Aim 3. Test the activity of metabolic inhibitors against cells in arid conditions in vitro and in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment
-
批准号:10205608
-
项目类别:
-
资助金额:$59.87万
-
财政年份:2021
-
负责人:CHI V. DANG
-
依托单位:
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment
-
批准号:10396617
-
项目类别:
-
资助金额:$10.35万
-
财政年份:2021
-
负责人:CHI V. DANG
-
依托单位:
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment
-
批准号:10728412
-
项目类别:
-
资助金额:$46.22万
-
财政年份:2021
-
负责人:CHI V. DANG
-
依托单位:
MYC Oncogene Hubsite
-
批准号:6474169
-
项目类别:
-
资助金额:$6.6万
-
财政年份:2001
-
负责人:CHI V. DANG
-
依托单位:
MYC Oncogene Hubsite
-
批准号:6528030
-
项目类别:
-
资助金额:$6.6万
-
财政年份:2001
-
负责人:CHI V. DANG
-
依托单位:
MYC Oncogene Hubsite
-
批准号:6651086
-
项目类别:
-
资助金额:$6.6万
-
财政年份:2001
-
负责人:CHI V. DANG
-
依托单位:
FASEB conference on Hematological Malignancies
-
批准号:6359970
-
项目类别:
-
资助金额:$0.85万
-
财政年份:2001
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:8710658
-
项目类别:
-
资助金额:$1.25万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:9131243
-
项目类别:
-
资助金额:$12.5万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:8402161
-
项目类别:
-
资助金额:$721.69万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:8998395
-
项目类别:
-
资助金额:$797.55万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
DEVELOPMENTAL FUNDS (Core 002)
-
批准号:8998398
-
项目类别:
-
资助金额:$99.53万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
PLANNING AND EVALUATION (Core 001)
-
批准号:8998397
-
项目类别:
-
资助金额:$5.27万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:9338556
-
项目类别:
-
资助金额:$50.0万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:8789009
-
项目类别:
-
资助金额:$7.5万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:8300800
-
项目类别:
-
资助金额:$772.51万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:9378876
-
项目类别:
-
资助金额:$12.5万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
C-MYC TARGETS IN THE PATHOGENESIS OF HUMAN CANCERS
-
批准号:3201669
-
项目类别:
-
资助金额:$23.34万
-
财政年份:1992
-
负责人:CHI V. DANG
-
依托单位:
C-MYC TARGETS IN THE PATHOGENESIS OF HUMAN CANCERS
-
批准号:3201668
-
项目类别:
-
资助金额:$22.4万
-
财政年份:1992
-
负责人:CHI V. DANG
-
依托单位:
C MYC TARGETS IN THE PATHOGENESIS OF HUMAN CANCERS
-
批准号:6375935
-
项目类别:
-
资助金额:$40.95万
-
财政年份:1992
-
负责人:CHI V. DANG
-
依托单位:
海外基金